Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium
The levonorgestrel-releasing intrauterine system reduced cell proliferation and steroid receptor expression while increasing Fas expression in endometriosis lesions and normal endometrium.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (50)
- Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis via openalex
- Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis via openalex
- Augmented cell survival in eutopic endometrium from women with endometriosis: Expression of c-myc, TGF-beta1 and bax genes via openalex
- Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study via openalex
- Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium via openalex
- Endometrial Anomalies in Women with Endometriosis via openalex
- Endometriosis: Immunohistochemical analysis of oestrogen and progesterone receptors in endometriotic tissue and endometrium via openalex
- Gonadotropin-releasing hormone agonist induces apoptosis and reduces cell proliferation in eutopic endometrial cultures from women with endometriosis via openalex
- Gonadotropin-releasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro via openalex
- Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis via openalex
- Immunohistochemical characterization of proliferation, oestrogen receptor and progesterone receptor expression in endometriosis: comparison of eutopic and ectopic endometrium with normal cycling endometrium via openalex
- Immunohistochemical Study of Angiogenic Factors in Endometrium and Endometriosis via openalex
- Oral contraceptives treatment suppresses proliferation and enhances apoptosis of eutopic endometrial tissue from patients with endometriosis. via openalex
- Quantitative analysis of estrogen receptor alpha and beta messenger ribonucleic acid levels in normal endometrium and ovarian endometriotic cysts using a real-time reverse transcription-polymerase chain reaction assay via openalex
- Relationship between apoptosis and the number of macrophages in eutopic endometrium from women with and without endometriosis via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Spontaneous Apoptosis of Endometrial Tissue is Impaired in Women with Endometriosis via openalex
- The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up via openalex
- The gonadotropin-releasing hormone agonist leuprolide acetate induces apoptosis and suppresses cell proliferative activity in rectovaginal endometriosis via openalex
- The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis via openalex
- The levonorgestrel-releasing intrauterine system and endometriosis staging via openalex
- TISSUE CONCENTRATIONS OF LEVONORGESTREL IN WOMEN USING A LEVONORGESTREL‐RELEASING IUD via openalex
- W2152487546 via openalex
- W161896645 via openalex
- W2295266478 via openalex
- W2296293854 via openalex
- W2308719376 via openalex
- W2497418601 via openalex
- W2166744769 via openalex
- W181227182 via openalex
- W1579407907 via openalex
- W1607777232 via openalex
- W1966954962 via openalex
- W1967734681 via openalex
- W1981344902 via openalex
- W1982881537 via openalex
- W2004993064 via openalex
- W2014219458 via openalex
- W2034864360 via openalex
- W2037697411 via openalex
- W2058692557 via openalex
- W2062248137 via openalex
- W2068240610 via openalex
- W2072380594 via openalex
- W2114697800 via openalex
- W2123134517 via openalex
- W2127301754 via openalex
- W2130958783 via openalex
- W2141524334 via openalex
- W2147018260 via openalex
Cited by (44)
- Endometriosis is not the endometrium: Reviewing the over-representation of eutopic endometrium in endometriosis research 2025
- Biological characteristics related to treatment effects of the levonorgestrel-releasing intrauterine system on adenomyosis-associated dysmenorrhoea 2024
- The role of levonorgestrel-releasing intrauterine system for recurrence prevention after conservative surgery among patients with coexistent ovarian endometrioma and diffuse adenomyosis: A retrospective case control study with long-term follow up 2023
- Is endometriosis due to evolutionary maladaptation? 2023
- Progesterone Resistance in Endometriosis: Current Evidence and Putative Mechanisms 2023
- Endometriosis - Recent Advances, New Perspectives and Treatments 2021
- Potential Therapeutic Options and Perspectives for Alleviation of Endometrial Estrogen Dominance and Progesterone Resistance in Endometriosis 2021
- Medical management of endometriosis 2021
- PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis 2020
- Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure 2020
- PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis 2019
- Endometriosis 2019
- Effect of pretreatment with a levonorgestrel-releasing intrauterine system on IVF and vitrified–warmed embryo transfer outcomes in women with adenomyosis 2019
- Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis 2018
- Tratamientos farmacológicos de la endometriosis (a excepción de la adenomiosis) 2018
- Characteristics of Women with Recurrent Endometriosis Pain after Laparoscopy and Levonorgestrel Intrauterine Device Placement 2017
- Progesterone resistance in endometriosis: origins, consequences and interventions 2017
- Investigational Medical Therapies for Endometriosis: Current Data and Future Trends 2017
- Oral and depot progestin therapy for endometriosis: towards a personalized medicine 2017
- Influência de agentes antiangiogênicos (propranolol) em endometriose experimentalmente induzida em ratas 2017
- Immunohistochemical Analysis of the Effect of Dienogest on Ovarian Endometriotic Cysts 2016
- New paradigms in the diagnosis and management of endometriosis 2016
- Dienogest reduces proliferation, NGF expression and nerve fiber density in human adenomyosis 2016
- Hormonal therapy for endometriosis: from molecular research to bedside 2016
- Differential mRNA expression profiling in ovarian endometriotic tissue with versus without leuprolide acetate treatment 2015
- Emerging therapy for endometriosis 2015
- New trends of progestins treatment of endometriosis 2014
- Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis 2014
- Hormonal Treatment for Severe Hydronephrosis Caused by Bladder Endometriosis 2014
- Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis 2013
- Postoperative levonorgestrel‐releasing intrauterine system versus oral contraceptives after gonadotropin‐releasing hormone agonist treatment for preventing endometrioma recurrence 2013
- Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis 2013
- Long-term regression of experimental endometriosis in a rat model treated with local application of levonorgestrel-loaded biodegradable microspheres 2012
- Neuroendocrine Aspects of Endometriosis‐Associated Pain 2011
- 异常在位子宫内膜是内异症的病因吗?-在位内膜在内异症发病中的作用 2011
- Medical Therapies: Progestins 2011
- Changes in glandular and stromal estrogen and progesterone receptor isoform expression in eutopic and ectopic endometrium following treatment with the levonorgestrel-releasing intrauterine system 2011
- Expression patterns of Aurora A and B kinases, Ki-67 and the estrogen and progesterone receptors determined using an endometriosis tissue microarray model 2011
- Emerging indications for the levonorgestrel‐releasing intrauterine system (LNG‐IUS) 2011
- Levonorgestrel‐releasing intrauterine system (Mirena <sup>®</sup> ) and Depot medroxyprogesterone acetate (Depoprovera) as long‐term maintenance therapy for patients with moderate and severe endometriosis: A randomised controlled trial 2010
- Apoptosis and endometriosis 2010
- An update on adenomyosis in the adolescent 2010
- Hormonal contraceptives and endometriosis/adenomyosis 2010
- 10.1016/s0246-1064(17)67531-5 2000
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:13:59.677786+00:00